To assess the impact of prematurity-associated nephrocalcinosis on kidney f
unction; later in life, 20 premature children with neonatal nephrocalcinosi
s and 20 controls, matched for birth weight and postnatal age but without n
ephrocalcinosis, were examined (birth weight 905+/-209 vs. 957+/-226 g; stu
dy age 4.7+/-1.1 vs. 4.6+/-0.9 years). Distal tubular acidification capacit
y was measured with the oral acetazolamide test, in which the response was
abnormal in 1 out of the 20 children with a history of nephrocalcinosis, bu
t in none of the controls. Urinary calcium and beta(2)-microglobulin excret
ion were higher in the children with nephrocalcinosis, but no differences w
ere found in fractional excretion of sodium and potassium or tubular reabso
rption of phosphate. Estimated creatinine clearance was not different betwe
en the groups. Of the 6 children with nephrocalcinosis lasting beyond 2 yea
rs of age, 5 had had chronic lung disease neonatally and exhibited a tenden
cy for compensated respiratory acidosis at the time of the examination. Neo
natal nephrocalcinosis seems to lead to some signs of renal tubular dysfunc
tion in early childhood of preterm infants. Glomerular function, however, a
ppears not to be specifically disturbed by nephrocalcinosis.